David Alland

23.2k total citations · 5 hit papers
135 papers, 11.7k citations indexed

About

David Alland is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, David Alland has authored 135 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Infectious Diseases, 104 papers in Epidemiology and 33 papers in Molecular Biology. Recurrent topics in David Alland's work include Tuberculosis Research and Epidemiology (101 papers), Mycobacterium research and diagnosis (88 papers) and Infectious Diseases and Tuberculosis (20 papers). David Alland is often cited by papers focused on Tuberculosis Research and Epidemiology (101 papers), Mycobacterium research and diagnosis (88 papers) and Infectious Diseases and Tuberculosis (20 papers). David Alland collaborates with scholars based in United States, Switzerland and South Africa. David Alland's co-authors include Soumitesh Chakravorty, William R. Jacobs, Manzour Hernando Hazbón, Nancy Connell, Michele Burday, Catharina Boehme, Pamela Nabeta, Martin Jones, Camilla Rodrigues and Robert Blakemore and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

David Alland

131 papers receiving 11.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rapid Molecular Detection of Tuberculosis and Rifampin Resistance

2010 1.6k citations Catharina Boehme, Pamela Nabeta et al. profile →
A detailed analysis of 16S ribosomal RNA gene segments for the diagnosis of pathogenic bacteria

2007 832 citations Soumitesh Chakravorty, David Alland et al. profile →
Transmission of Tuberculosis in New York City -- An Analysis by DNA Fingerprinting and Conventional Epidemiologic Methods

1994 646 citations David Alland, Barry R. Bloom et al. profile →
Better Tests, Better Care: Improved Diagnostics for Infectious Diseases

2013 461 citations Angela M. Caliendo, David N. Gilbert et al. Clinical Infectious Diseases profile →
SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis

2012 381 citations David Alland, Clifton E. Barry et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Alland United States	52	8.4k	7.0k	3.4k	3.3k	895	135	11.7k
William R. Bishai United States	73	11.1k 1.3×	8.5k 1.2×	5.9k 1.7×	3.1k 0.9×	1.6k 1.8×	314	17.2k
Daniela María Cirillo Italy	55	6.7k 0.8×	5.6k 0.8×	2.2k 0.7×	2.9k 0.9×	685 0.8×	297	9.9k
Peter W. M. Hermans Netherlands	59	7.3k 0.9×	10.1k 1.5×	2.5k 0.7×	3.3k 1.0×	831 0.9×	251	14.6k
Roland Brosch France	70	11.2k 1.3×	9.8k 1.4×	4.0k 1.2×	2.8k 0.9×	1.5k 1.6×	177	15.8k
Warwick J. Britton Australia	62	6.8k 0.8×	5.5k 0.8×	2.8k 0.8×	1.8k 0.5×	303 0.3×	315	14.2k
JoAnne L. Flynn United States	81	17.0k 2.0×	12.4k 1.8×	4.3k 1.3×	5.0k 1.5×	727 0.8×	205	23.8k
Françoise Portaels Belgium	61	8.3k 1.0×	10.7k 1.5×	1.7k 0.5×	3.1k 0.9×	634 0.7×	268	13.2k
Stephen H. Gillespie United Kingdom	52	6.0k 0.7×	5.4k 0.8×	1.7k 0.5×	1.8k 0.5×	1.1k 1.2×	263	10.2k
Stefan Niemann Germany	65	12.3k 1.5×	11.5k 1.7×	3.0k 0.9×	5.6k 1.7×	1.1k 1.2×	301	14.8k
Timothy D. McHugh United Kingdom	48	5.7k 0.7×	4.5k 0.6×	2.0k 0.6×	1.9k 0.6×	815 0.9×	234	9.0k

Countries citing papers authored by David Alland

Since Specialization

Citations

This map shows the geographic impact of David Alland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Alland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Alland more than expected).

Fields of papers citing papers by David Alland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Alland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Alland. The network helps show where David Alland may publish in the future.

Co-authorship network of co-authors of David Alland

This figure shows the co-authorship network connecting the top 25 collaborators of David Alland. A scholar is included among the top collaborators of David Alland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Alland. David Alland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Banada, Padmapriya P., et al.. (2023). Persistence of SARS-CoV-2 in saliva: Implications for late-stage diagnosis and infectious duration. PLoS ONE. 18(3). e0282708–e0282708. 3 indexed citations

Levy, Shawn, et al.. (2022). Origin and Dynamics of Mycobacterium tuberculosis Subpopulations That Predictably Generate Drug Tolerance and Resistance. mBio. 13(6). e0279522–e0279522. 8 indexed citations

Banada, Padmapriya P., et al.. (2021). Sample collection and transport strategies to enhance yield, accessibility, and biosafety of COVID-19 RT-PCR testing. Journal of Medical Microbiology. 70(9). 8 indexed citations

Parmar, Heta, Rajiv L. Gaur, Simone Battaglia, et al.. (2020). Xpert MTB/XDR: a 10-Color Reflex Assay Suitable for Point-of-Care Settings To Detect Isoniazid, Fluoroquinolone, and Second-Line-Injectable-Drug Resistance Directly from Mycobacterium tuberculosis-Positive Sputum. Journal of Clinical Microbiology. 59(3). 57 indexed citations

Colangeli, Roberto, Aditi Gupta, Solange Alves Vinhas, et al.. (2020). Mycobacterium tuberculosis progresses through two phases of latent infection in humans. Nature Communications. 11(1). 4870–4870. 52 indexed citations

Schumacher, Samuel G., William A. Wells, Mark P. Nicol, et al.. (2019). Guidance for Studies Evaluating the Accuracy of Sputum-Based Tests to Diagnose Tuberculosis. The Journal of Infectious Diseases. 220(Supplement_3). S99–S107. 20 indexed citations

Safi, Hassan, Pooja Gopal, Shuyi Ma, et al.. (2019). Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance. Proceedings of the National Academy of Sciences. 116(39). 19665–19674. 97 indexed citations

Verma, Sheetal, Kamlesh Bhatt, Rodrigo Ribeiro‐Rodrigues, et al.. (2019). Transmission phenotype of Mycobacterium tuberculosis strains is mechanistically linked to induction of distinct pulmonary pathology. PLoS Pathogens. 15(3). e1007613–e1007613. 33 indexed citations

Shenai, Shubhada, Katharina Ronacher, Kim Stanley, et al.. (2016). Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB. PLoS ONE. 11(8). e0160062–e0160062. 29 indexed citations

10.

Salamon, Hugh, Ken Yamaguchi, Daniela María Cirillo, et al.. (2015). Integration of Published Information Into a Resistance-Associated Mutation Database for Mycobacterium tuberculosis. The Journal of Infectious Diseases. 211(suppl_2). S50–S57. 26 indexed citations

11.

Colangeli, Roberto, Ray Cursons, Noel Karalus, et al.. (2014). Whole Genome Sequencing of Mycobacterium tuberculosis Reveals Slow Growth and Low Mutation Rates during Latent Infections in Humans. PLoS ONE. 9(3). e91024–e91024. 64 indexed citations

12.

Caliendo, Angela M., David N. Gilbert, Christine C. Ginocchio, et al.. (2013). Better Tests, Better Care: Improved Diagnostics for Infectious Diseases. Clinical Infectious Diseases. 57(suppl 3). S139–S170. 461 indexed citations breakdown →

13.

Blakemore, Robert, Pamela Nabeta, Amy L. Davidow, et al.. (2011). A Multisite Assessment of the Quantitative Capabilities of the Xpert MTB/RIF Assay. American Journal of Respiratory and Critical Care Medicine. 184(9). 1076–1084. 91 indexed citations

14.

Manning, Shannon D., Alifiya S. Motiwala, A. Cody Springman, et al.. (2008). Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proceedings of the National Academy of Sciences. 105(12). 4868–4873. 339 indexed citations

15.

Zhang, Wei, Weihong Qi, Thomas J. Albert, et al.. (2006). Probing genomic diversity and evolution of Escherichia coli O157 by single nucleotide polymorphisms. Genome Research. 16(6). 757–767. 86 indexed citations

16.

Colangeli, Roberto, Sudharsan Sridharan, Jingchuan Sun, et al.. (2005). The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol. Molecular Microbiology. 55(6). 1829–1840. 140 indexed citations

17.

Kuo, Mack, Héctor R. Morbidoni, David Alland, et al.. (2003). Targeting Tuberculosis and Malaria through Inhibition of Enoyl Reductase. Journal of Biological Chemistry. 278(23). 20851–20859. 218 indexed citations

18.

Gingeras, T, Ghassan Ghandour, Eugene Wang, et al.. (1998). Simultaneous Genotyping and Species Identification Using Hybridization Pattern Recognition Analysis of Generic Mycobacterium DNA Arrays. Genome Research. 8(5). 435–448. 190 indexed citations

19.

Horn, David L., Dial Hewlett, Ashok Kumar Patel, et al.. (1996). CLINICAL EXPERIENCE WITH RIFAMPIN-ISONIAZID-STREPTOMYCIN-ETHAMBUTOL (RISE)-RESISTANT TUBERCULOSIS. Infectious Diseases in Clinical Practice. 5(1). 68–72. 2 indexed citations

20.

Mehra, V., Barry R. Bloom, Peter A. Sieling, et al.. (1992). A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein.. The Journal of Experimental Medicine. 175(1). 275–284. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact